Search Results 321-330 of 16682 for anti-TNF drugs
Anti-CTLA-4 therapies: Patients who have received prior treatment with anti ... medications: treatment with systemic immunosuppressive medications ... TNF] agents) ...
Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...
William Freeman, M.D.. Pharmacogenomics testing can also play a key role in identifying those patients who take anti-seizure medications who may be at risk for ...
Patients who have the CYP2C19 gene variants may be good candidates for alternative anti-platelet therapy. The trial focused on people with the loss of function ...
Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... Anti-TNFα agents except for etanercept (e.g., infliximab): 60 days ...
... anti-Crohn's therapy. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore® Bio-A® fistula plug as per ...
... anti-tumor activity of GEN3017 as a monotherapy ... Drugs used in chemotherapy, such as doxorubicin ... therapy or for whom there is no standard therapy.
Intravitreous anti-vascular endothelial growth factor (anti-VEGF) therapy alone or vitrectomy combined with intraoperative PRP each provide the opportunity to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.